Ophthalmic Viscoelastic Devices Market Research — Overview & Industry Outlook

 What Are Ophthalmic Viscoelastic Devices (OVDs)?

Ophthalmic Viscoelastic Devices (OVDs) are specialized gel-like materials used during eye surgeries — particularly intraocular procedures — to maintain space within the eye, offer protection to delicate ocular tissues, and support better surgical outcomes. According to the report, their effectiveness has contributed to increased success rates in procedures such as lens implantation and cataract surgeries.

Market Forecast & Key Numbers

• The global OVD market Size is projected to reach around USD 1,900 million by 2028.
• The forecast is based on a compound annual growth rate (CAGR) of 10.5% over the period 2023–2028.

 

Major Market Drivers

The growth of the OVD market is driven by:

·       An increasing number of cataract and glaucoma surgeries, which depend on viscoelastic devices to ensure safe and effective outcomes.

·       Ongoing developments in OVD technology/materials — enhancing their performance and reliability in surgeries.

·       Favorable reimbursement policies in various regions, which make it easier for hospitals and clinics to procure and use OVDs.

 

Market Segmentation

The report segments the market across multiple dimensions:

By Product Type:

• Cohesive OVDs
• Dispersive OVDs

By Application (Surgical Use):

• Cataract Surgery
• Glaucoma Surgery
• Corneal Transplantation
• Vitreoretinal Surgery

By End-User / Buyer:

• Ophthalmic Clinics & Phaco Centers
• Hospitals
• Academic & Research Institutes

By Region / Geography:

• North America, Europe, Asia-Pacific, and other global regions, with country-level detail including the U.S., Canada, UK, Germany, China, Japan, India, Brazil, GCC countries, among others.

 

Leading Industry Players

Some of the major companies active in the Ophthalmic Viscoelastic Devices Market, as listed in the report, include:

·       Johnson & Johnson

·       Alcon Laboratories Inc.

·       Bausch & Lomb

·       Carl Zeiss AG

·       Rayner Company

·       (Also mentioned: a few other smaller players or emerging firms in certain regional markets.)

 

Market Challenges / Constraints

Even with strong growth prospects, the report notes certain restraints that may affect the pace of market adoption:

·       Lack of general awareness about OVDs in some regions — particularly where modern ophthalmic services are less accessible.

·       Availability of alternative therapy methods in certain markets, which may compete with or reduce demand for viscoelastic-assisted surgeries.

 

What the Report Offers for Stakeholders

For readers, investors, manufacturers, healthcare providers, or ophthalmic clinics — the report provides:

·       A broad market overview and forecast of OVD demand and growth through 2028.

·       Insight into segmentation (by product type, surgery application, end-user, and region) — helping stakeholders identify target markets and growth segments.

·       Competitive analysis and profiling of major industry players, enabling benchmarking and strategic planning.

·       Opportunities for customized research according to specific client requirements.

 

Why This Market Matters (for Healthcare and Industry)

The growing demand for eye surgeries — especially cataract and glaucoma treatments — globally drives the need for reliable, high-quality OVDs. As surgeons increasingly rely on advanced viscoelastic materials to ensure safety and success in delicate intraocular procedures, the OVD market becomes a critical segment within ophthalmic devices.

Moreover, as medical infrastructure improves, and access to surgical eye care expands around the world (including developing regions), OVDs are likely to see even greater adoption. For manufacturers and distributors, this signifies a growing opportunity; for hospitals and clinics, quality OVD supply becomes integral to providing modern eye-care services.